Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Other Working Capital Changes (2019 - 2025)

Pulmonx (LUNG) has disclosed Other Working Capital Changes for 7 consecutive years, with $913000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 208.45% to $913000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.4 million, a 843.53% decrease, with the full-year FY2024 number at -$1.9 million, down 9250.0% from a year prior.
  • Other Working Capital Changes was $913000.0 for Q3 2025 at Pulmonx, up from -$791000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $3.1 million in Q4 2021 to a low of -$2.2 million in Q4 2024.
  • A 5-year average of -$86421.1 and a median of -$13000.0 in 2023 define the central range for Other Working Capital Changes.
  • Biggest YoY gain for Other Working Capital Changes was 3060.0% in 2024; the steepest drop was 13668.75% in 2024.
  • Pulmonx's Other Working Capital Changes stood at $3.1 million in 2021, then tumbled by 66.76% to $1.0 million in 2022, then tumbled by 98.43% to $16000.0 in 2023, then plummeted by 13668.75% to -$2.2 million in 2024, then surged by 142.05% to $913000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Other Working Capital Changes are $913000.0 (Q3 2025), -$791000.0 (Q2 2025), and -$308000.0 (Q1 2025).